CDC Media Telebriefing: Update on Respiratory Disease Circulation Transcript
CDC Media Telebriefing: Update on Respiratory Disease Circulation Transcript
CDC Media Telebriefing: Update on Respiratory Disease Circulation Transcript
The Centers for Disease Control and Prevention (CDC) is releasing updated and expanded recommendations for clinicians providing pain care for adult outpatients with short- and long-term pain.
CDC Director Dr. Rochelle P. Walensky experienced mild symptoms from her recent COVID-19 infection, completed a course of Paxlovid, and, after a period of isolation, tested negative for the virus.
Overall cancer death rates continued to decline among men, women, children, and adolescents and young adults in every major racial and ethnic group in the United States from 2015 to 2019, according to the latest Annual Report to the Nation on the Status of Cancer.
Last night, CDC Director Dr. Rochelle Walensky tested positive for COVID-19. She is up to date with her vaccines. Dr. Walensky is experiencing mild symptoms.
Today, CDC’s Advisory Committee on Immunization Practices (ACIP) recommended updates to the 2023 childhood and adult <a href="https://www.cdc.gov/vaccines/schedules/index.html">immunization schedules</a>, which includes incorporating additional information for approved or authorized COVID-19 vaccines.
Today, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.
Today, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.
Black, Hispanic, and American Indian/Alaska Native (AI/AN) adults in the United States are more likely to be hospitalized with flu, as well as less likely to be vaccinated against flu, according to a new CDC <em>Vital Sign</em>s report.
The Uganda Ministry of Health (MOH) announced the first positive case of Ebola virus disease (EVD) in Uganda in 2022 caused by Sudan virus (species <em>Sudan ebolavirus)</em> on September 20.